Medications for Acute Coronary Syndromes
KEYWORDS: patients, orally, risk, heparin, pci, day, used, hours, bleeding, given, nitroglycerin, therapy, coronary, use, acs

in patients with followed by 25 Argatroban ACS and a known or mcg/kg/minute (IV suspected history of infusion) heparin-induced Bivalirudin Variable† thrombocytopenia Anticoagulants: Factor Xa inhibitor As an alternative to heparin in patients with 2.5 mg subcutaneously ACS and a known or Fondaparinux every 24 hours suspected history of heparin-induced thrombocytopenia Anticoagulants: Low molecular weight heparins Dalteparin Variable† Patients with unstable angina or NSTEMI Enoxaparin¶ Patients < 75 years Tinzaparin receiving tenecteplase Medication Dosage Use Almost all patients with STEMI as an alternative to unfractionated heparin (unless PCI is indicated and can be done in < 90 minutes); drug continued until PCI or CABG is done or patient is discharged Anticoagulants: Unfractionated heparin Patients with unstable angina or NSTEMI: 60–70 units/kg IV (maximum, 5000 units; bolus), followed by 12–15 units/kg/hour (maximum, Patients with unstable 1000 units/hour) for 48 angina or NSTEMI as an hours or until PCI is alternative to enoxaparin complete Patients who have STEMI Unfractionated heparin Patients with STEMI: 60 and undergo urgent units/kg IV (maximum, angiography and PCI or 4000 units; bolus) given patients > 75 years when alteplase, reteplase, receiving tenecteplase or tenecteplase is started, then followed by 12 units/kg/hour (maximum, 1000 units/hour) for 48 hours
